Comparison of Different Drug Susceptibility Test Methods To Detect Rifampin Heteroresistance in Mycobacterium tuberculosis

ABSTRACT We compared the efficiencies of different drug susceptibility testing methods in detecting rifampin (RIF) heteroresistance in Mycobacterium tuberculosis. Our data revealed that the broth dilution method found more resistance than MGIT did (P = 0.046) for the low-resistance group. Similarly, the broth dilution method was more sensitive in detecting RIF heteroresistance in subpopulations with low growth rates than was MGIT (P = 0.033). In conclusion, our data demonstrated that the broth dilution method was more sensitive than MGIT in detecting RIF heteroresistance.

[1]  Sarman Singh,et al.  High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. , 2014, Tuberculosis.

[2]  K. Kam,et al.  Ethambutol Resistance as Determined by Broth Dilution Method Correlates Better than Sequencing Results with embB Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates , 2013, Journal of Clinical Microbiology.

[3]  L. Rigouts,et al.  Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods , 2013, Journal of Clinical Microbiology.

[4]  L. Rigouts,et al.  Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard , 2013, Journal of Clinical Microbiology.

[5]  Suhua Zheng,et al.  Combining COLD-PCR and high-resolution melt analysis for rapid detection of low-level, rifampin-resistant mutations in Mycobacterium tuberculosis. , 2013, Journal of microbiological methods.

[6]  B. Zhao,et al.  Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China. , 2013, The Journal of antimicrobial chemotherapy.

[7]  S. Borrell,et al.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. , 2013, Trends in genetics : TIG.

[8]  M. Ehlers,et al.  Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa , 2012, BMC Infectious Diseases.

[9]  Shengfen Wang,et al.  Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.

[10]  Yu Wang,et al.  National survey of drug-resistant tuberculosis in China. , 2012, The New England journal of medicine.

[11]  B. Zhao,et al.  Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China , 2012, PloS one.

[12]  Pia Abel zur Wiesch,et al.  Population biological principles of drug-resistance evolution in infectious diseases. , 2011, The Lancet. Infectious diseases.

[13]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[14]  I. Bastian,et al.  Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results , 2009, Journal of Clinical Microbiology.

[15]  W. Gemert.  Guidelines for surveillance of drug resistance in tuberculosis , 2009 .

[16]  K. Kam,et al.  Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong , 2007, The Journal of antimicrobial chemotherapy.

[17]  F. Portaels,et al.  Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.

[18]  H. Rinder.  Hetero-resistance: an under-recognised confounder in diagnosis and therapy? , 2001, Journal of medical microbiology.

[19]  Robert H. Gilman,et al.  Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.

[20]  M. Aziz,et al.  Guidelines for surveillance of drug resistance in tuberculosis , 2009 .

[21]  L. Heifets,et al.  Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan. , 1988, The American review of respiratory disease.